The Artemisinic Acid Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Antimalarial Injections, Antimalarial Tablets).
The Artemisinic Acid Market in 2024 is witnessing significant growth, driven by the increasing demand for artemisinin-derived compounds, expanding applications in pharmaceuticals and agrochemicals, and advancements in biotechnology and synthetic biology to produce artemisinic acid through sustainable and cost-effective manufacturing processes. Artemisinic acid, a precursor to artemisinin, represents a key intermediate in the synthesis of artemisinin-based antimalarial drugs, which are widely used in the treatment of malaria, particularly drug-resistant strains. With advancements in metabolic engineering, fermentation technology, and enzyme optimization, the market offers innovative production platforms for artemisinic acid, including microbial fermentation, plant biotechnology, and synthetic biology approaches, enabling scalable and efficient production of artemisinin precursors from renewable feedstocks. Moreover, the integration of supply chain optimization, quality control measures, and regulatory compliance further enhances the reliability, affordability, and sustainability of artemisinic acid production, driving market expansion and supporting global efforts to combat malaria and other infectious diseases.
A prominent trend in the Artemisinic Acid market is the growing demand for natural and sustainable ingredients in pharmaceuticals. Artemisinic acid, derived from the Artemisia annua plant, is gaining traction in the pharmaceutical industry due to its potent antimalarial properties and potential therapeutic applications beyond malaria treatment. As consumers increasingly prioritize natural and plant-based remedies, pharmaceutical companies are exploring the use of artemisinic acid as a key ingredient in drug formulations for various diseases, driving market growth.
A key driver fueling the Artemisinic Acid market is the rising incidence of malaria and the emergence of drug-resistant strains. Malaria remains a significant global health challenge, particularly in regions with limited access to healthcare and effective antimalarial treatments. Artemisinin-based combination therapies (ACTs), which contain artemisinic acid derivatives, are considered the gold standard for malaria treatment. However, the increasing prevalence of drug-resistant malaria strains underscores the urgent need for alternative antimalarial drugs, stimulating demand for artemisinic acid and its derivatives as potential therapeutic options to combat drug resistance.
An opportunity in the Artemisinic Acid market lies in the expansion of production capabilities and the optimization of the supply chain to meet growing demand. As the pharmaceutical industry explores the therapeutic potential of artemisinic acid beyond malaria treatment, there is a need for increased production of high-quality artemisinic acid at scale. Companies involved in artemisinic acid production can leverage advancements in biotechnology, plant breeding, and agricultural practices to enhance yield, purity, and sustainability while ensuring compliance with Good Agricultural and Collection Practices (GACP). Furthermore, strategic partnerships and collaborations across the value chain, including growers, processors, manufacturers, and distributors, can streamline production processes, improve market access, and ensure reliable supply of artemisinic acid to meet global healthcare needs.
By Type
Antimalarial Injections
Antimalarial Tablets
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AdvacarePharma
Calyx Chemicals and Pharmaceuticals Ltd
Cipla Inc
Guilin Pharmaceutical Co. Ltd
Ipca Laboratories Ltd
KPC Pharmaceuticals Inc
Novartis AG
Rupus Global Ltd
Sanofi
Shin Poong Pharm Co. Ltd
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Artemisinic Acid Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Artemisinic Acid Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Artemisinic Acid Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Artemisinic Acid Market Size Outlook, $ Million, 2021 to 2030
3.2 Artemisinic Acid Market Outlook by Type, $ Million, 2021 to 2030
3.3 Artemisinic Acid Market Outlook by Product, $ Million, 2021 to 2030
3.4 Artemisinic Acid Market Outlook by Application, $ Million, 2021 to 2030
3.5 Artemisinic Acid Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Artemisinic Acid Market Industry
4.2 Key Market Trends in Artemisinic Acid Market Industry
4.3 Potential Opportunities in Artemisinic Acid Market Industry
4.4 Key Challenges in Artemisinic Acid Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Artemisinic Acid Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Artemisinic Acid Market Outlook By Segments
7.1 Artemisinic Acid Market Outlook by Segments
By Type
Antimalarial Injections
Antimalarial Tablets
8 North America Artemisinic Acid Market Analysis And Outlook To 2030
8.1 Introduction to North America Artemisinic Acid Markets in 2024
8.2 North America Artemisinic Acid Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Artemisinic Acid Market size Outlook by Segments, 2021-2030
By Type
Antimalarial Injections
Antimalarial Tablets
9 Europe Artemisinic Acid Market Analysis And Outlook To 2030
9.1 Introduction to Europe Artemisinic Acid Markets in 2024
9.2 Europe Artemisinic Acid Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Artemisinic Acid Market Size Outlook By Segments, 2021-2030
By Type
Antimalarial Injections
Antimalarial Tablets
10 Asia Pacific Artemisinic Acid Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Artemisinic Acid Markets in 2024
10.2 Asia Pacific Artemisinic Acid Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Artemisinic Acid Market size Outlook by Segments, 2021-2030
By Type
Antimalarial Injections
Antimalarial Tablets
11 South America Artemisinic Acid Market Analysis And Outlook To 2030
11.1 Introduction to South America Artemisinic Acid Markets in 2024
11.2 South America Artemisinic Acid Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Artemisinic Acid Market size Outlook by Segments, 2021-2030
By Type
Antimalarial Injections
Antimalarial Tablets
12 Middle East And Africa Artemisinic Acid Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Artemisinic Acid Markets in 2024
12.2 Middle East and Africa Artemisinic Acid Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Artemisinic Acid Market size Outlook by Segments, 2021-2030
By Type
Antimalarial Injections
Antimalarial Tablets
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AdvacarePharma
Calyx Chemicals and Pharmaceuticals Ltd
Cipla Inc
Guilin Pharmaceutical Co. Ltd
Ipca Laboratories Ltd
KPC Pharmaceuticals Inc
Novartis AG
Rupus Global Ltd
Sanofi
Shin Poong Pharm Co. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Antimalarial Injections
Antimalarial Tablets
The global Artemisinic Acid Market is one of the lucrative growth markets, poised to register a 4.6% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AdvacarePharma, Calyx Chemicals and Pharmaceuticals Ltd, Cipla Inc, Guilin Pharmaceutical Co. Ltd, Ipca Laboratories Ltd, KPC Pharmaceuticals Inc, Novartis AG, Rupus Global Ltd, Sanofi, Shin Poong Pharm Co. Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume